Department of Neurosurgery, University of Rochester, Rochester, New York, USA.
Department of Neurosurgery, University of Rochester, Rochester, New York, USA.
World Neurosurg. 2024 May;185:e1230-e1243. doi: 10.1016/j.wneu.2024.03.061. Epub 2024 Mar 19.
For patients with medically refractory epilepsy, newer minimally invasive techniques such as laser interstitial thermal therapy (LITT) have been developed in recent years. This study aims to characterize trends in the utilization of surgical resection versus LITT to treat medically refractory epilepsy, characterize complications, and understand the cost of this innovative technique to the public.
The National Inpatient Sample database was queried from 2016 to 2019 for all patients admitted with a diagnosis of medically refractory epilepsy. Patient demographics, hospital length of stay, complications, and costs were tabulated for all patients who underwent LITT or surgical resection within these cohorts.
A total of 6019 patients were included, 223 underwent LITT procedures, while 5796 underwent resection. Significant predictors of increased patient charges for both cohorts included diabetes (odds ratio: 1.7, confidence interval [CI]: 1.44-2.19), infection (odds ratio: 5.12, CI 2.73-9.58), and hemorrhage (odds ratio: 2.95, CI 2.04-4.12). Procedures performed at nonteaching hospitals had 1.54 greater odds (CI 1.02-2.33) of resulting in a complication compared to teaching hospitals. Insurance status did significantly differ (P = 0.001) between those receiving LITT (23.3% Medicare; 25.6% Medicaid; 44.4% private insurance; 6.7 Other) and those undergoing resection (35.3% Medicare; 22.5% Medicaid; 34.7% private Insurance; 7.5% other). When adjusting for patient demographics, LITT patients had shorter length of stay (2.3 vs. 8.9 days, P < 0.001), lower complication rate (1.9% vs. 3.1%, P = 0.385), and lower mean hospital ($139,412.79 vs. $233,120.99, P < 0.001) and patient ($55,394.34 vs. $37,756.66, P < 0.001) costs.
The present study highlights LITT's advantages through its association with lower costs and shorter length of stay. The present study also highlights the associated predictors of LITT versus resection, such as that most LITT cases happen at academic centers for patients with private insurance. As the adoption of LITT continues, more data will become available to further understand these issues.
对于药物难治性癫痫患者,近年来开发了一些新的微创技术,如激光间质热疗(LITT)。本研究旨在描述采用手术切除与 LITT 治疗药物难治性癫痫的趋势,描述并发症,并了解该创新技术对公众的成本。
2016 年至 2019 年,从全国住院患者样本数据库中检索出所有诊断为药物难治性癫痫并入院的患者。对所有在这些队列中接受 LITT 或手术切除的患者进行患者人口统计学、住院时间、并发症和费用的表列。
共纳入 6019 例患者,223 例接受 LITT 治疗,5796 例接受切除术。两个队列中增加患者费用的显著预测因素包括糖尿病(比值比:1.7,置信区间[CI]:1.44-2.19)、感染(比值比:5.12,CI 2.73-9.58)和出血(比值比:2.95,CI 2.04-4.12)。与教学医院相比,在非教学医院进行的手术发生并发症的几率高出 1.54 倍(CI 1.02-2.33)。保险状况在接受 LITT 治疗的患者(23.3%医疗保险;25.6%医疗补助;44.4%私人保险;6.7%其他)和接受手术切除的患者(35.3%医疗保险;22.5%医疗补助;34.7%私人保险;7.5%其他)之间存在显著差异(P = 0.001)。在调整患者人口统计学因素后,LITT 患者的住院时间更短(2.3 天与 8.9 天,P < 0.001),并发症发生率更低(1.9%与 3.1%,P = 0.385),平均住院费用(139412.79 美元与 233120.99 美元,P < 0.001)和患者费用(55394.34 美元与 37756.66 美元,P < 0.001)也更低。
本研究通过与较低的成本和较短的住院时间相关联,强调了 LITT 的优势。本研究还强调了 LITT 与切除术相关的相关预测因素,例如,大多数 LITT 病例发生在学术中心,患者为私人保险。随着 LITT 的采用继续增加,将获得更多数据来进一步了解这些问题。